Together, administration of Ltf results in lower expression of collagen-related genes (Col1A1 and Col3A1) and fibrosis-associated genes (α-SMA, Postn and Fn1), and reduces myocardial apoptosis post-MI which may contribute to attenuating cardiac fibrosis. The gene discussed is COL3A1; the disease is myocardial infarction.